Interim report January - September 2017
Continued strong momentum in Biotage’s operations Third quarter · Net sales amounted to 177.7 MSEK (167.0), which is an increase by 6.4 percent compared to the corresponding quarter last year. At comparable exchange rates* net sales increased by 9.8 percent. · Operating profit increased by 7.5 percent to 29.3 MSEK (27.2). · Result after tax increased by 12.4 percent to 31.1 MSEK (27.7). · Earnings per share amounted to 0.48 SEK (0.43) before and after dilution. · The cash flow from operating activities amounted to 30.5 MSEK (30.8). · Net cash* at September 30 amounted